These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 38744865)

  • 1. Targeting tumor suppressor p53 for organ fibrosis therapy.
    Bao YN; Yang Q; Shen XL; Yu WK; Zhou L; Zhu QR; Shan QY; Wang ZC; Cao G
    Cell Death Dis; 2024 May; 15(5):336. PubMed ID: 38744865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Snai1-induced partial epithelial-mesenchymal transition orchestrates p53-p21-mediated G2/M arrest in the progression of renal fibrosis via NF-κB-mediated inflammation.
    Qi R; Wang J; Jiang Y; Qiu Y; Xu M; Rong R; Zhu T
    Cell Death Dis; 2021 Jan; 12(1):44. PubMed ID: 33414422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin Targets p53-Fibrinolytic System in TGF-β1 Mediated Alveolar Epithelial Mesenchymal Transition in Alveolar Epithelial Cells.
    Shaikh SB; Prabhu A; Bhandary YP
    Endocr Metab Immune Disord Drug Targets; 2021; 21(8):1441-1452. PubMed ID: 32990549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of a potential therapeutic target NPAS2, regulated by p53, alleviates pulmonary fibrosis by inhibiting epithelial-mesenchymal transition via suppressing HES1.
    Chen Y; He Z; Zhao B; Zheng R
    Cell Signal; 2023 Sep; 109():110795. PubMed ID: 37406788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 and Myofibroblast Apoptosis in Organ Fibrosis.
    McElhinney K; Irnaten M; O'Brien C
    Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chk2 Modulates Bmi1-Deficiency-Induced Renal Aging and Fibrosis via Oxidative Stress, DNA Damage, and p53/TGFβ1-Induced Epithelial-Mesenchymal Transition.
    Lu J; Sun W; Liu B; Zhang J; Wang R; Goltzman D; Miao D
    Int J Biol Sci; 2024; 20(6):2008-2026. PubMed ID: 38617548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caveolin-1-Related Intervention for Fibrotic Lung Diseases.
    Shetty S; Idell S
    Cells; 2023 Feb; 12(4):. PubMed ID: 36831221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast Growth Factor 21 Attenuates Diabetes-Induced Renal Fibrosis by Negatively Regulating TGF-β-p53-Smad2/3-Mediated Epithelial-to-Mesenchymal Transition via Activation of AKT.
    Lin S; Yu L; Ni Y; He L; Weng X; Lu X; Zhang C
    Diabetes Metab J; 2020 Feb; 44(1):158-172. PubMed ID: 31701691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Senescence and aging: the critical roles of p53.
    Rufini A; Tucci P; Celardo I; Melino G
    Oncogene; 2013 Oct; 32(43):5129-43. PubMed ID: 23416979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs in kidney fibrosis and diabetic nephropathy: roles on EMT and EndMT.
    Srivastava SP; Koya D; Kanasaki K
    Biomed Res Int; 2013; 2013():125469. PubMed ID: 24089659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging Non-Canonical Functions and Regulation by p53: p53 and Stemness.
    Olivos DJ; Mayo LD
    Int J Mol Sci; 2016 Nov; 17(12):. PubMed ID: 27898034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. F-box protein FBXO31 modulates apoptosis and epithelial-mesenchymal transition of cervical cancer via inactivation of the PI3K/AKT-mediated MDM2/p53 axis.
    Liu K; Xue B; Bai G; Zhang W
    Life Sci; 2020 Oct; 259():118277. PubMed ID: 32800832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of tumour suppressor PTEN expression in renal injury initiates SMAD3- and p53-dependent fibrotic responses.
    Samarakoon R; Helo S; Dobberfuhl AD; Khakoo NS; Falke L; Overstreet JM; Goldschmeding R; Higgins PJ
    J Pathol; 2015 Aug; 236(4):421-32. PubMed ID: 25810340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vincamine Ameliorates Epithelial-Mesenchymal Transition in Bleomycin-Induced Pulmonary Fibrosis in Rats; Targeting TGF-β/MAPK/Snai1 Pathway.
    Alaaeldin R; Mohyeldin RH; Bekhit AA; Gomaa W; Zhao QL; Fathy M
    Molecules; 2023 Jun; 28(12):. PubMed ID: 37375218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pterostilbene prevents hepatocyte epithelial-mesenchymal transition in fructose-induced liver fibrosis through suppressing miR-34a/Sirt1/p53 and TGF-β1/Smads signalling.
    Song L; Chen TY; Zhao XJ; Xu Q; Jiao RQ; Li JM; Kong LD
    Br J Pharmacol; 2019 Jun; 176(11):1619-1634. PubMed ID: 30632134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging role of tumor suppressor p53 in acute and chronic kidney diseases.
    Overstreet JM; Gifford CC; Tang J; Higgins PJ; Samarakoon R
    Cell Mol Life Sci; 2022 Aug; 79(9):474. PubMed ID: 35941392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alveolar epithelial cells in idiopathic pulmonary fibrosis display upregulation of TRAIL, DR4 and DR5 expression with simultaneous preferential over-expression of pro-apoptotic marker p53.
    Akram KM; Lomas NJ; Forsyth NR; Spiteri MA
    Int J Clin Exp Pathol; 2014; 7(2):552-64. PubMed ID: 24551275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serpine 1 induces alveolar type II cell senescence through activating p53-p21-Rb pathway in fibrotic lung disease.
    Jiang C; Liu G; Luckhardt T; Antony V; Zhou Y; Carter AB; Thannickal VJ; Liu RM
    Aging Cell; 2017 Oct; 16(5):1114-1124. PubMed ID: 28722352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-β1/p53 signaling in renal fibrogenesis.
    Higgins SP; Tang Y; Higgins CE; Mian B; Zhang W; Czekay RP; Samarakoon R; Conti DJ; Higgins PJ
    Cell Signal; 2018 Mar; 43():1-10. PubMed ID: 29191563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrosis and cancer: shared features and mechanisms suggest common targeted therapeutic approaches.
    Landolt L; Spagnoli GC; Hertig A; Brocheriou I; Marti HP
    Nephrol Dial Transplant; 2022 May; 37(6):1024-1032. PubMed ID: 33280031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.